Navigation Links
Pennsylvania Hospital Pays $1.9 Million to Settle Medicare Fraud Case Brought by Whistleblower
Date:11/24/2008

Inflated Medicare reimbursement claims alleged in "qui tam" lawsuit

ERIE, Pa., Nov. 24 /PRNewswire/ -- St. Vincent Health System Inc., based in Erie, Pennsylvania, has agreed to pay $1.9 million to the federal government to settle a whistleblower lawsuit that alleged the hospital submitted reimbursement claims to Medicare that greatly exceeded its actual costs.

The settlement by St. Vincent -- filed in district court in Newark, New Jersey, today - is the latest of several settlements by hospitals named in a "qui tam" (whistleblower) lawsuit brought in 2005 by Anthony Kite, an independent hospital consultant in New Jersey.

Kite alleged in his lawsuit that St. Vincent inflated its reimbursement claims to Medicare from 2001 to 2003 to receive supplemental, or "outlier," payments. Similar allegations were made against the other hospitals. The Medicare program makes outlier payments to hospitals when the actual costs for treating a particular patient greatly exceed a predetermined reimbursement amount for that type of treatment.

"The outlier program has been vulnerable to fraud by healthcare providers," said Larry P. Zoglin, a San Francisco attorney with Phillips & Cohen, which is representing the whistleblower in the qui tam case. "In numerous instances, whistleblowers have exposed this drain on Medicare."

Most qui tam lawsuits succeed only if the government joins the case. But for the second time in Kite's lawsuit, Phillips & Cohen secured a settlement for the federal government without government intervention. Last month, St. Joseph Healthcare System Inc. paid $1.75 million to the federal government to settle its case.

Cooper University Hospital in Camden, New Jersey paid $3.85 million to settle a case brought by Kite. In addition, Kite was one of several whistleblowers who brought successful qui tam lawsuits against Warren Hospital in Phillipsburg, New Jersey (which settled for $7.5 million); Bayonne Medical Center in Bayonne, New Jersey ($2.5 million); Cathedral Healthcare System, in Newark, New Jersey ($5.3 million); and Raritan Bay Medical Center in Perth Amboy, New Jersey ($7.5 million).

Phillips & Cohen is the largest and most successful law firm that specializes exclusively in representing whistleblowers in qui tam lawsuits and tax fraud matters. Cases brought by the firm on behalf of whistleblowers have returned nearly $3 billion to the federal government.

For more information about Phillips & Cohen, qui tam lawsuits and tax fraud whistleblowers, see www.phillipsandcohen.com.

Case citation: U.S. ex rel. Kite v. Besler Consulting, et al, Case No. 05 :CV3066 (D.N.J.)


'/>"/>
SOURCE Phillips & Cohen LLP
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute
2. Pennsylvania Health Department Reminds Parents to Immunize Their Children Against Pertussis
3. Pennsylvania Insurance Department Approves Launch of Senior Health Care Oversight Trust
4. Conseco Completes Transfer of Senior Health Insurance Company of Pennsylvania to Independent Trust
5. Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania
6. Highmark Healthy High 5 School Challenge Grant Program Enables Pennsylvania Schools to Implement or Enhance Healthy Lifestyle Programs for Students
7. Pennsylvania Patient Safety Authority Hires Director of Educational Programs
8. NAMI Pennsylvania Announces Program for Annual Statewide Conference
9. Pilot Program Successfully Addresses Mental Health Issues in Pennsylvanias Children
10. Level III Trauma Center Accreditation Status for Pennsylvania
11. Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: